NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
Tahereh Yavari: DOACs vs Warfarin in Antiphospholipid Syndrome
Tahereh Yavari/LinkedIn
Oct 28, 2025, 15:35

Tahereh Yavari: DOACs vs Warfarin in Antiphospholipid Syndrome

Tahereh Yavari, Assistant Professor at Tehran University of Medical Sciences, shared a post on LinkedIn about a paper by Alessandra Ida Celia et al. published in Seminars in Arthritis and Rheumatism:

“DOACs vs Warfarin in Antiphospholipid Syndrome: What Does the Evidence Say in 2025?

A major new systematic review and meta-analysis by Alessandra Ida Celia, Giovanni Maria Vescovo, Cristiano Alessandri, Fabrizio Conti, Behnood Bikdeli, Michelle Petri, Andrea Fava, Mattia Galli published in Seminars in Arthritis and Rheumatism (2025), sheds new light on one of the most debated clinical questions in APS management.

The Numbers Tell the Story

Across 12 studies (4 RCTs + 8 observational; 1,307 patients)

  • Composite thrombotic events were > 2× higher with DOACs vs VKAs – IRR 2.33 (95 % CI 1.18 – 4.58)
  • Arterial thrombosis risk tripled – IRR 2.70 (1.42 – 5.13)
  • Venous thrombosis: no significant difference – IRR 0.98 (0.59 – 1.64)
  • Major bleeding: similar between groups – IRR 0.83 (0.48 – 1.43)

Interestingly, in a small subgroup, combining DOACs + a single antiplatelet agent seemed to mitigate arterial risk — a hypothesis that calls for future trials.

Clinical Message

Despite their convenience, DOACs may not be safe in high-risk APS, especially in patients with arterial events or triple-positive profiles.

Warfarin remains the gold standard.

The findings emphasize the need for precision anticoagulation strategies and better biomarkers to guide therapy in APS.

This meta-analysis reinforces the critical message: not all thromboses are the same, and not all anticoagulants are interchangeable.”

Title: Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis

Authors: Alessandra Ida Celia, Giovanni Maria Vescovo, Gianmarco Sarto, Cristiano Alessandri, Antonio Iaconelli, Domenico D’Amario, Giacomo Frati, Fabrizio Conti, Sebastiano Sciarretta, Dominick J. Angiolillo, Andrea Fava, Michelle A. Petri, Behnood Bikdeli, Mattia Galli

Read the full article.

Tahereh Yavari

Stay updated on all scientific advances in the field of fertility with Fertility News.

Alessandra Ida Celia Andrea Fava Antiphospholipid Syndrome APS Behnood Bikdeli Cristiano Alessandri DOACs Fabrizio Conti Fertility Fertility News Giovanni Maria Vescovo Mattia Galli Michelle Petri Tahereh Yavari thrombotic Warfarin
NewsFeed